Navegação por assunto "SARS-CoV"
Itens para a visualização no momento 61-80 of 128
-
Informe epidemiológico Nº 32 enfermedad por SARS-CoV-2 (COVID-19) Chile 10-07-2020. Departamento de Epidemiología
(2020-07-10)Este informe entrega información actualizada sobre la situación epidemiológica de COVID-19 en Chile, en base a datos disponibles hasta el 9 de julio de 2020 a las 06:00 h. La información se entrega a nivel país, regional ... -
Informe epidemiológico Nº 33 enfermedad por SARS-CoV-2 (COVID-19) Chile 13-07-2020. Departamento de Epidemiología
(2020-07-13)Este informe entrega información actualizada sobre la situación epidemiológica de COVID-19 en Chile, en base a datos disponibles hasta el 12 de julio de 2020 a las 06:00 h. La información se entrega a nivel país, regional ... -
Inhibition of the replication of SARS-CoV-2 in human cells by the FDA-approved drug chlorpromazine
(2020-05-06)Urgent action is needed to fight the ongoing COVID-19 pandemic by reducing the number of infected people along with the infection contagiousness and severity. Chlorpromazine (CPZ), the prototype of typical antipsychotics ... -
Interim Analysis of Pandemic Coronavirus Disease 2019 (COVID-19) and the SARS-CoV-2 virus in Latin America and the Caribbean: Morbidity, Mortality and Molecular Testing Trends in the Region
(2020-04-29)Background: The relentless advance of the SARS-CoV-2 virus pandemic has resulted in a significant burden on countries, regardless of their socio-economic conditions. The virus has infected more than 2.5 million people ... -
Interim Guidance for COVID-19 and Persons with HIV
(2020-03-20)This interim guidance reviews special considerations for persons with HIV and their health care providers in the United States regarding COVID-19. Information and data on COVID-19 are rapidly evolving. This guidance includes ... -
Investigational COVID-19 Convalescent Plasma - Emergency INDs
(2020-03-24)The Food and Drug Administration (FDA or Agency) plays a critical role in protecting the United States from public health threats including the Coronavirus Disease 2019 (COVID-19) pandemic. FDA is committed to doing ... -
Lianhuaqingwen Exerts Anti-Viral and Anti-Inflammatory Activity Against Novel Coronavirus (SARS-CoV-2)
(2020-03-20)Purpose: Lianhuaqingwen (LH) as traditional Chinese medicine (TCM) formula has been used to treat influenza and exerted broad-spectrum antiviral effects on a series of influenza viruses and immune regulatory effects [1]. ... -
Lineamientos de prevención y control para casos sospechosos o confirmados de SARS CoV-2/COVID-19. (2020)
(2020)Objetivo: Establecer lineamientos de prevención y control para la atención de casos sospechosos o confirmados de infección por el virus SARS CoV-2 / COVID-19 en diferentes ámbitos de acción. -
Listado de test rápido para detección de anticuerpos CoVID-19 de la Autoridades Reguladoras Nacionales pertenecientes al Foro Internacional de Reguladores de Dispositivos Médicos
(2020-04-03)El Instituto de Salud Pública de Chile (ISP) informa el listado de kit de anticuerpos IgG e IgM que se encuentran reportados en los sitios web oficiales de las autoridades reguladoras de alta vigilancia sanitaria en ... -
Listado de test rápido para detección de anticuerpos CoVID-19 de la Autoridades Reguladoras Nacionales pertenecientes al Foro Internacional de Reguladores de Dispositivos Médicos
(2020-04-14)El Instituto de Salud Pública de Chile (ISP) informa el listado de kit de anticuerpos IgG e IgM que se encuentran reportados en los sitios web oficiales de autoridades reguladoras de alta vigilancia sanitaria en dispositivos ... -
Mathematical Modeling & the Transmission Dynamics of SARS-CoV-2 in Cali, Colombia: Implications to a 2020 Outbreak & public health preparedness
(2020-05-10)Introduction: As SARS-COV-2 and the disease COVID-19 is sweeping through countries after countries around the globe, it is critical to understand potential burden of a future outbreak in cities of Colombia. This pandemic ... -
MERS-CoV as an emerging respiratory illness: A review of prevention methods
(2019-12)Introduction: Middle East Respiratory Coronavirus Virus (MERS-CoV) first emerged from Saudi Arabia in 2012 and has since been recognized as a significant human respiratory pathogen on a global level. Methods: In this ... -
Meta-analysis of diagnostic performance of serological tests for SARS-CoV-2 antibodies and public health implications
(2020-05-08)Serology-based tests have become a key public health element in the COVID-19 pandemic to assess the degree of herd immunity that has been achieved in the population. These tests differ between one another in several ways. ... -
Methods of An Open-Label Proof-Of-Concept Trial of Intravenous Valproic Acid for Severe COVID-19
(2020-05-01)Background: Coronavirus disease 2019 (COVID-19) is the systemic entity caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) that may cause death through severe atypical pneumonia and acute lung injury. ... -
Modelling of Systemic versus Pulmonary Chloroquine Exposure in Man for COVID-19 Dose Selection
(2020-05-01)Chloroquine has attracted intense attention as a potential clinical candidate for prevention and treatment of COVID-19 based on reports of in-vitro efficacy against SARS-CoV-2. While the pharmacokinetic-pharmacodynamic ... -
Molecular detection of SARS-CoV-2 using a reagent-free approach
(2020-05-02)Shortage of reagents and consumables required for the extraction and molecular detection of SARS-CoV-2 RNA in respiratory samples has led many laboratories to investigate alternative approaches for sample preparation. ... -
Monolaurina na prevenção e tratamento de pacientes com COVID-19, maio de 2020
(2020-05)Esta nota técnica tem por objetivo apresentar informações sobre o uso da monolaurina na prevenção e no tratamento de pacientes com COVID-19. -
More than just smell - COVID-19 is associated with severe impairment of smell, taste, and chemesthesis
(2020-05-08)Recent anecdotal and scientific reports have provided evidence of a link between COVID-19 and chemosensory impairments such as anosmia. However, these reports have downplayed or failed to distinguish potential effects on ... -
Nota Informativa: Recomendações para adequações das ações de vigilância e cuidado ao paciente com doença de Chagas frente à situação epidemiológica da COVID-19 (15 de abril de 2020)
(2020-04-15)A doença de Chagas (DC) é uma condição crônica, que leva aproximadamente 40% dos indivíduos infectados a desenvolverem sinais clínicos com envolvimento cardíaco e digestivo. Estima-se que esta população no país seja em ...